Warning! GuruFocus detected
1 Severe warning sign
with 0JDM.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description

IQVIA Holdings Inc
NAICS : 621399
SIC : 8099
ISIN : US46266C1053
Description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 2.33 | |||||
Debt-to-EBITDA | 4.1 | |||||
Interest Coverage | 3.39 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.03 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.7 | |||||
3-Year EBITDA Growth Rate | 9.9 | |||||
3-Year EPS without NRI Growth Rate | 29.3 | |||||
3-Year FCF Growth Rate | -0.8 | |||||
3-Year Book Growth Rate | 2.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 9.72 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.25 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.33 | |||||
9-Day RSI | 35.33 | |||||
14-Day RSI | 37.92 | |||||
3-1 Month Momentum % | -6.19 | |||||
6-1 Month Momentum % | -20.19 | |||||
12-1 Month Momentum % | -26.1 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.84 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.26 | |||||
Days Sales Outstanding | 32.38 | |||||
Days Payable | 84.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 2.6 | |||||
Shareholder Yield % | 4.44 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.89 | |||||
Operating Margin % | 14.73 | |||||
Net Margin % | 8.91 | |||||
FCF Margin % | 13.72 | |||||
ROE % | 21.32 | |||||
ROA % | 5.13 | |||||
ROIC % | 7.59 | |||||
3-Year ROIIC % | 31.05 | |||||
ROC (Joel Greenblatt) % | 298.11 | |||||
ROCE % | 11.67 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.65 | |||||
Forward PE Ratio | 15 | |||||
PE Ratio without NRI | 15.92 | |||||
Shiller PE Ratio | 38.92 | |||||
Price-to-Owner-Earnings | 16.83 | |||||
PEG Ratio | 1.11 | |||||
PS Ratio | 2.11 | |||||
PB Ratio | 5.15 | |||||
Price-to-Free-Cash-Flow | 15.36 | |||||
Price-to-Operating-Cash-Flow | 11.96 | |||||
EV-to-EBIT | 18.64 | |||||
EV-to-Forward-EBIT | 16.68 | |||||
EV-to-EBITDA | 12.62 | |||||
EV-to-Forward-EBITDA | 12.94 | |||||
EV-to-Revenue | 2.83 | |||||
EV-to-Forward-Revenue | 2.73 | |||||
EV-to-FCF | 20.62 | |||||
Price-to-GF-Value | 0.74 | |||||
Price-to-Projected-FCF | 1.18 | |||||
Price-to-DCF (Earnings Based) | 0.7 | |||||
Price-to-DCF (FCF Based) | 0.64 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.08 | |||||
Earnings Yield (Greenblatt) % | 5.36 | |||||
FCF Yield % | 6.76 | |||||
Forward Rate of Return (Yacktman) % | 20.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IQVIA Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 15,405 | ||
EPS (TTM) ($) | 7.5 | ||
Beta | 0.99 | ||
3-Year Sharpe Ratio | -0.23 | ||
3-Year Sortino Ratio | -0.36 | ||
Volatility % | 25.61 | ||
14-Day RSI | 37.92 | ||
14-Day ATR ($) | 4.039184 | ||
20-Day SMA ($) | 184.243165 | ||
12-1 Month Momentum % | -26.1 | ||
52-Week Range ($) | 176.27 - 252.9 | ||
Shares Outstanding (Mil) | 176.32 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IQVIA Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IQVIA Holdings Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
IQVIA Holdings Inc Frequently Asked Questions
What is IQVIA Holdings Inc(LTS:0JDM)'s stock price today?
The current price of LTS:0JDM is $178.15. The 52 week high of LTS:0JDM is $252.90 and 52 week low is $176.27.
When is next earnings date of IQVIA Holdings Inc(LTS:0JDM)?
The next earnings date of IQVIA Holdings Inc(LTS:0JDM) is 2025-05-02 Est..
Does IQVIA Holdings Inc(LTS:0JDM) pay dividends? If so, how much?
IQVIA Holdings Inc(LTS:0JDM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |